Company profile

Equashield

Equashield, founded in 2009 and headquartered in Port Washington, New York, is a leading medical device company specializing in closed-system transfer devices (CSTDs) for the safe handling of hazardous drugs. The company raised $300 million in its Series D round in October 2022, led by Nordic Capital, reaching a $1.3 billion valuation. With 59 employees, Equashield develops advanced solutions like EQUASHIELD Pro, an automated compounding robot enhancing precision, safety, and efficiency in drug preparation.

Back to profiles

Quick facts

Total funding: $300 million
Valuation: $1.3 billion
Founded: 2009
Headquarters: Port Washington, New York
Employees: 59

Notable investors

Nordic Capital

Reach buyers like Equashield on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Equashield
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Equashield.

The 14-day trial ships every feature, no card required.

Start free →